How 200-year old Scottish technology is making the future of medicine cooler
Asymptote’s digitally-enabled cryogenic cold chain technology supports safe manufacture and delivery of cellular therapies
GE Healthcare acquires Asymptote
GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies. The acquisition further strengthens GE Healthcare’s cell therapy portfolio with a suite of technologies for the cryopreservation of cellular materials
Cook Regentec and Asymptote introduce the CellSeal® Automated Thawing System
Indianapolis, US, and Cambridge UK, 29th November 2016 Cook Regentec, focused on developing research and clinical tools to advance regenerative medicine therapies from the lab to the patient, and Asymptote Ltd., specialists in cryochain for regenerative medicine, today announced the launch of the CellSeal® Automated Thawing System.
New software platform controls the cryogenic cold chain for cellular therapies
Asymptote Ltd, specialists in cryochain technology for advanced medicines, has announced the commercial launch of my.Cryochain, a software platform developed specifically to give centralised control of the cryogenic cold chain for cellular therapies.
Cell Therapy Catapult and Asymptote collaborate to revolutionise delivery of cell therapies
The Cell Therapy Catapult and Asymptote, a leading specialist in cryopreservation based in Cambridge, are combining forces to advance the development of a novel point-of-care Thawing System for Cell Based Therapies.
Asymptote launches the VIA Freeze range of controlled rate freezers at ISCT Paris
Cambridge-based cryopreservation specialists Asymptote Ltd will launch its unique range of liquid nitrogen free controlled rate freezers specially designed for the needs of regenerative medicine at the annual meeting of the International Society for Cellular Therapy (ISCT) to be held in Paris.
New technology from Asymptote will improve third world vaccine storage and distribution
Cambridge-based cryopreservation specialists Asymptote Ltd, has been awarded a grant from the Technology Strategy Board to develop ways of improving the storage of live vaccines for use in the third world. Asymptote is developing ultra low temperature storage equipment which could help prevent vaccines from being discarded unnecessarily.